Neuroone Medical Technologies (NMTC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NMTC Annual Balance Sheets →
A period-by-period view of the balance sheet from Neuroone Medical Technologies to Mar 31 2025 helps clarify how Mar 31 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent2.80
Cash & Short-term Investments2.00
Accounts receivable1.90
Inventories1.87
Derivatives, Collateral, Regulatory, Deferred0.02
Prepaid Expense And Other Assets Current0.28
Total Current Assets7.40
Equipment/Property/Plant Net0.23
Intangible Assets0.03
Other Assets, Noncurrent0.20
Operating Lease Right Of Use Asset0.20
Total Assets7.86
Liabilities
Accounts Payable, Current AC0.93
Accrued Liabilities, Current AC0.76
Other Liabilities, Current0.00
Total Current Liabilities1.69
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.00
Other liabilities, Noncurrent0.80
OperatingLeaseLiabilityNoncurrent0.09
Total Liabilities2.49
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock87.50
Retained Earnings / Accumulated Deficit-82.13
Defined Benefit Plan and Other0.71
Other Equity-0.71
Common Stockholder's Equity5.37
Total Stockholder's Equity5.37
Liabilities & Stockholder's Equity7.86
4 historic quarters locked

Sign in to unlock the full Neuroone Medical Technologies balance sheet history.

About Neuroone Medical Technologies Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-088724

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.